Skip to content
OpenCapital
Get started

Castle Biosciences CSTL Enterprise value

Enterprise value at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$28.24B+10.2%
Veracyte logo
VeracyteVCYT
$2.33B+7.4%
Personalis, Inc. logo
Personalis, Inc.PSNL
$631.91M+125%
NeoGenomics logo
NeoGenomicsNEO
$883.35M-5.6%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$481.38M+4.6%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$6.02B+951%

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$694.86M+29.9%
P/S2×+0.5×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×

Where this comes from

Calculated from Castle Biosciences’s reported figures.

$729.9Mmarket cap+$36.7Mtotal debt−$63.8Mcash and equivalents=$702.86M

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Castle Biosciences's enterprise value?
Castle Biosciences (CSTL) reported enterprise value of $702.86M in Q1 2026.
How has Castle Biosciences's enterprise value changed year-over-year?
Castle Biosciences's enterprise value increased by 38.6% year-over-year, from $507.01M to $702.86M.
What is the long-term trend for Castle Biosciences's enterprise value?
Over 4 years (2021 to 2025), Castle Biosciences's enterprise value has grown at a 8.4% compound annual growth rate (CAGR), from $763.3M to $1.06B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.